Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.410
-0.060 (-1.73%)
Mar 9, 2026, 2:03 PM CET
221.70%
Market Cap 88.33M
Revenue (ttm) 12.29M
Net Income (ttm) -8.06M
Shares Out 25.45M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,889
Average Volume 16,556
Open 3.460
Previous Close 3.470
Day's Range 3.110 - 3.520
52-Week Range 0.920 - 7.760
Beta 1.30
RSI 43.91
Earnings Date Feb 17, 2026

About Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 1
Stock Exchange Nasdaq Stockholm
Ticker Symbol CMOTEC.B
Full Company Profile

Financial Performance

In 2025, Scandinavian ChemoTech AB's revenue was 12.29 million, an increase of 87.10% compared to the previous year's 6.57 million. Losses were -8.06 million, -41.27% less than in 2024.

Financial Statements

News

There is no news available yet.